@xconomy.com 4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@techcrunch.com 6 years ago
Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics
@venturebeat.com 7 years ago
Seven Bridges Announces Scientific Advisory Board
@WIRED 7 years ago
A cure for cancer, diabetes, and heart disease might be found in your DNA—if doctors can access.
@theverge.com 9 years ago
England will sequence the genomes of 100,000 humans to tackle cancer and rare diseases